(Q36900721)

English

Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events

scientific article published on July 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

0 references

1 reference

Europe PubMed Central

Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Jeffrey Weber

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

864-872

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Identifiers

10.1634/THEONCOLOGIST.12-7-864

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36900721&oldid=2088442040"